In the present work, we have assayed both the in vitro and in vivo action of two acridine compounds against Leishmania donovani. As part of this effort, we have studied the possible action mechanism of these compounds at the ultrastructural and biochemical levels and in relation to the synthesis of macromolecules. The two acridinones inhibit the in vitro growth of the promastigote forms of L. donovani at the highest concentration assayed (100 μg/ml). The in vivo results indicate that both compounds reduce the number of amastigotes per gram of spleen, and decrease parasitism, by more than 40%. With respect to the action mechanism, both compounds inhibit the incorporation of [3H]thymidine, inducing alterations at the ultrastructural level in the DNA and mitochondria. Alterations are also caused in the enzymes of the Krebs cycle.
CITATION STYLE
Mesa-Valle, C. M., Castilla-Calvente, J., Sanchez-Moreno, M., Moraleda-Lindez, V., Barbe, J., & Osuna, A. (1996). Activity and mode of action of acridine compounds against Leishmania donovani. Antimicrobial Agents and Chemotherapy, 40(3), 684–690. https://doi.org/10.1128/aac.40.3.684
Mendeley helps you to discover research relevant for your work.